Take note, Dr. Sacha, see how easy it is to mentio
Post# of 158771
Quote:
”This led to the breakthrough discovery that the CCR5 GPCR receptor plays a key role in the fight against breast cancer. Using the Leronlimab anti-CCR5 monoclonal antibody, we developed a therapy that significantly reduces side effects for patients, requiring only a single injection,” explained Professor Pestell.